Exchange: OTC·Updated 03:42 PM EDT
Upcoming Earnings: Q2 '26

Reports: Aug 12After Hours

Estimated EPS

-$0.01

Estimated Rev

$39.8M

$MRMD Q1 '26 Earnings Results & Recap MariMed reported Q1 2026 revenue of $39.5M, an increase from $37.9M in Q1 2025, and Non-GAAP Adjusted EBITDA grew to $3.6M from $2.5M, expanding its margin to 9%.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '26
-$0.01
--
--
N/A
Q1 '26
-$0.01
-$0.01
20.44%
BEAT
Q4 '25
-$0.01
$0.01
155.65%
BEAT
Q3 '25
-$0.01
-$0.01
--
EXPECTED
Q2 '25
-$0.01
$0.00
100.00%
BEAT

Advertisement|Remove ads.